• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BDTX-189 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3846829

BDTX-189 is a potent, orally active and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations, including EGFR/HER2 exon 20 insertion mutants. BDTX-189 shows KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively. Anticancer… More details

$175 / 5 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BDTX-189, Inhibitor
Full Product Name
BDTX-189
Product Gene Name
Purity/Purification
>98%
Preparation and Storage
Store at -20 degree C for ~2 years
Molecular Weight
561.03
Solubility
DMSO
CAS No.
2414572-47-5
Formula
C29H29ClN6O4
SMILES
C=CC(NC1=CC2=C(NC3=CC=C(OCC4=NC=CC=C4)C(Cl)=C3)N=CN=C2C=C1OCCN5CCOCC5)=O
Availability
We cannot ship this item to Switzerland, Italy, Germany, France and Austria.

Product Categories/Family for BDTX-189, inhibitor

Chemical Structure of BDTX-189, inhibitor

BDTX-189 Inhibitor – Cat# MBS3846829

Other Notes

Small volumes of BDTX-189, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BDTX-189 purchase

MBS3846829 is an inhibitor targeting BDTX-189.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000